N18.6

End stage renal disease

## Clinical Definition and Overview End-Stage Renal Disease (ESRD), also identified as Stage 5 Chronic Kidney Disease (CKD) requiring renal replacement therapy (RRT), represents the final, permanent stage of chronic kidney disease. It is characterized by the irreversible loss of kidney function to a degree that is no longer compatible with life without medical intervention. Clinically, ESRD is defined by a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 m², or the clinical necessity for dialysis or kidney transplantation. At this stage, the kidneys have lost approximately 85% to 90% of their functional capacity, leading to a profound accumulation of metabolic waste products, fluid overload, and systemic physiological derangements. ## Pathophysiology The progression to ESRD involves a common pathway of nephron loss, regardless of the initial insult. Chronic injury triggers compensatory hypertrophy of remaining nephrons, which initially maintains GFR but eventually leads to intraglomerular hypertension and hyperfiltration. This process results in progressive glomerular sclerosis, tubulointerstitial fibrosis, and further nephron loss. As the nephron population declines, the kidney loses its ability to concentrate urine, maintain electrolyte balance (notably potassium, phosphate, and calcium), and regulate acid-base status. Furthermore, the endocrine functions of the kidney fail, resulting in decreased production of erythropoietin (causing anemia) and impaired activation of Vitamin D (leading to mineral and bone disorders). ## Clinical Presentation and Diagnostic Criteria Patients with ESRD often present with the 'uremic syndrome,' a constellation of symptoms affecting nearly every organ system. Common findings include profound fatigue, uremic pruritus, anorexia, nausea, and peripheral edema. Advanced stages may lead to uremic encephalopathy, pericarditis, or asterixis. Diagnosis is primarily based on laboratory assessment of serum creatinine and calculated GFR. The ICD-10 code N18.6 is specifically used when a patient has reached the stage of kidney failure that requires chronic dialysis or has undergone a transplant, though the latter is often tracked with status codes (e.g., Z94.0). ## Management and Standard of Care The standard of care for ESRD involves Renal Replacement Therapy (RRT). This includes Hemodialysis (HD), Peritoneal Dialysis (PD), or Kidney Transplantation. Management also focuses on the complications of renal failure: erythropoiesis-stimulating agents (ESAs) and iron supplementation for anemia; phosphate binders and calcimimetics for secondary hyperparathyroidism; and strict blood pressure control. Dietetic intervention is crucial, focusing on the restriction of potassium, phosphorus, and sodium, while ensuring adequate protein intake for those on dialysis. Cardiovascular disease remains the leading cause of mortality in this population, requiring aggressive risk factor modification.

Clinical Symptoms

  • Fatigue and generalized weakness
  • Uremic pruritus (severe itching)
  • Peripheral edema (swelling of legs and ankles)
  • Shortness of breath (pulmonary edema)
  • Anorexia, nausea, and vomiting
  • Oliguria or anuria (decreased or absent urine output)
  • Cognitive impairment or 'brain fog'
  • Muscle cramps and restless leg syndrome
  • Metallic taste in the mouth (dysgeusia)
  • Uremic frost (rare, urea crystals on skin)

Common Causes

  • Diabetes Mellitus (Type 1 and Type 2)
  • Hypertension (Hypertensive nephrosclerosis)
  • Glomerulonephritis (e.g., IgA nephropathy, membranous nephropathy)
  • Polycystic Kidney Disease (PKD)
  • Systemic Lupus Erythematosus (Lupus Nephritis)
  • Chronic pyelonephritis and recurrent kidney infections
  • Obstructive uropathy (e.g., nephrolithiasis, BPH)
  • Alport Syndrome
  • Amyloidosis

Documentation & Coding Tips

Explicitly link End Stage Renal Disease (ESRD) to underlying etiologies such as Diabetes or Hypertension.

Example: Patient with Type 2 Diabetes Mellitus with diabetic nephropathy and End Stage Renal Disease (N18.6, E11.22). Currently stable on Monday-Wednesday-Friday hemodialysis via right-arm AV fistula. ESA therapy titrated for anemia of CKD (D63.1). This documentation supports the HCC 136 (Dialysis Status) and HCC 18 (Diabetes with Chronic Complications) risk adjustment models by establishing the causal link and current management status.

Billing Focus: Identify the primary underlying cause (E11.22 or I12.0) to satisfy 'code first' sequencing rules for ESRD.

Document dependence on renal dialysis (Z99.2) as a secondary code to N18.6 to confirm current treatment modality.

Example: Diagnosis: ESRD (N18.6) secondary to hypertensive nephrosclerosis. Patient is dialysis-dependent (Z99.2), receiving four-hour sessions at the outpatient center. No signs of catheter-related bloodstream infection at the tunneled PermCath site. Documentation of 'dialysis-dependent' ensures the encounter meets the criteria for HCC 136.

Billing Focus: Use Z99.2 as a required supplemental code to validate the use of N18.6 and justify dialysis-related CPT codes.

Specify associated complications like secondary hyperparathyroidism or renal osteodystrophy.

Example: Assessment: End stage renal disease (N18.6) with associated secondary hyperparathyroidism of renal origin (N25.81). Plan: Continue Sensipar 30mg daily and Calcitriol 0.25mcg. Monitoring PTH and Calcium levels monthly. High-complexity management due to mineral bone disease secondary to ESRD.

Billing Focus: Adds specificity to the metabolic complications associated with ESRD, justifying higher level E/M codes (e.g., 99215).

Document 'Anemia of Chronic Kidney Disease' rather than just 'Anemia'.

Example: Patient presents for dialysis. Hemoglobin 9.2 g/dL. Assessment: Anemia in chronic kidney disease (D63.1) due to ESRD (N18.6). Prescribed Procrit 10,000 units IV per session. Documentation links the anemia directly to the renal failure, supporting the use of ESA medications and Medicare Part B billing.

Billing Focus: D63.1 requires the underlying CKD/ESRD code to be sequenced first. Clear linkage is required for medical necessity of ESAs.

Differentiate between ESRD (N18.6) and CKD Stage 5 (N18.5) based on dialysis status.

Example: Patient has progressed from CKD Stage 5 to ESRD (N18.6) as they have initiated chronic maintenance hemodialysis this week. Patient no longer meets criteria for N18.5. This distinction is critical for accurate risk adjustment and facility billing.

Billing Focus: Prevents 'unspecified' or 'incorrect stage' denials. N18.6 is strictly for those who have reached the point of requiring chronic dialysis.

Relevant CPT Codes

Related Diagnoses

Hierarchy